Literature DB >> 33454759

Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group.

Hikaru Kubota1, Naoki Nakamura2, Naoto Shikama3, Ayako Tonari4, Hitoshi Wada5, Hideyuki Harada6, Hisayasu Nagakura7, Joichi Heianna8, Kei Ito9, Miwako Nozaki10, Masao Tago11, Masato Fushiki12, Nobue Uchida13, Norio Araki14, Shuhei Sekii1, Takashi Kosugi15, Takeo Takahashi16, Terufumi Kawamoto3, Tetsuo Saito17, Kazunari Yamada18.   

Abstract

Evidence regarding postoperative radiation therapy (PORT) for metastases to the long bones is lacking. Characterizing the current practice patterns and identifying factors that influence dose-fractionation schedules are essential for future clinical trials. An internet-based survey of the palliative RT subgroup of the Japanese Radiation Oncology Study Group was performed in 2017 to collect data regarding PORT prescription practices and dose-fractionation schedules. Responders were also asked to recommend dose-fractionation schedules for four hypothetical cases that involved a patient with impending pathological fractures and one of four clinical features (poor prognosis, solitary metastasis, radio-resistant primary tumor or expected long-term survival). Responders were asked to indicate their preferred irradiation fields and the reasons for the dose fractionation schedule they chose. Responses were obtained from 89 radiation oncologists (67 institutions and 151 RT plans) who used 22 dose-fractionation schedules, with the most commonly used and recommended schedule being 30 Gy in 10 fractions. Local control was the most common reason for preferring longer-course RT. High-dose fractionated schedules were preferred for oligometastasis, and low-dose regimens were preferred for patients with a poor prognosis; however, single-fraction RT was not preferred. Most respondents recommended targeting the entire orthopedic prosthesis. These results indicated that PORT using 30 Gy in 10 fractions to the entire orthopedic prosthesis is preferred in current Japanese practice and that single-fraction RT was not preferred. Oligometastasis and poor prognosis influenced the selection of high- or low-dose regimens.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

Entities:  

Keywords:  bone metastases; long bones; oligometastasis; patterns of practice; postoperative radiation therapy

Year:  2021        PMID: 33454759      PMCID: PMC7948830          DOI: 10.1093/jrr/rraa133

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  21 in total

1.  ACR Appropriateness Criteria® non-spine bone metastases.

Authors:  Stephen T Lutz; Simon Shek-Man Lo; Eric L Chang; Nicholas Galanopoulos; David D Howell; Edward Y Kim; Andre A Konski; Neeta D Pandit-Taskar; Samuel Ryu; Larry N Silverman; Catherine Van Poznak; Kristy L Weber
Journal:  J Palliat Med       Date:  2012-04-26       Impact factor: 2.947

2.  Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.

Authors:  Darby Erler; Drew Brotherston; Arjun Sahgal; Patrick Cheung; Andrew Loblaw; William Chu; Hany Soliman; Hans Chung; Alex Kiss; Edward Chow; Ian Poon
Journal:  Radiother Oncol       Date:  2018-04-26       Impact factor: 6.280

Review 3.  Incidence, prevalence and distribution of bone metastases.

Authors:  M Tubiana-Hulin
Journal:  Bone       Date:  1991       Impact factor: 4.398

4.  Malignant melanoma: analysis of dose fractionation in radiation therapy.

Authors:  J B Konefal; B Emami; M V Pilepich
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

5.  Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Gwendolyn Griffioen; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Glenn S Bauman; Andrew Warner; Suresh Senan
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

6.  Efficacy of postoperative radiation treatment for bone metastases in the extremities.

Authors:  Leah Drost; Vithusha Ganesh; Bo Angela Wan; Srinivas Raman; Stephanie Chan; Monique Christakis; May Tsao; Elizabeth Barnes; Michael Ford; Joel Finkelstein; Albert Yee; Angela Turner; Henry Lam; Edward Chow
Journal:  Radiother Oncol       Date:  2017-05-22       Impact factor: 6.280

7.  Update of the systematic review of palliative radiation therapy fractionation for bone metastases.

Authors:  Shayna E Rich; Ronald Chow; Srinivas Raman; K Liang Zeng; Stephen Lutz; Henry Lam; Maurício F Silva; Edward Chow
Journal:  Radiother Oncol       Date:  2018-02-01       Impact factor: 6.280

8.  Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease.

Authors:  P W Townsend; S R Smalley; S C Cozad; H G Rosenthal; R E Hassanein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-01-01       Impact factor: 7.038

9.  Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study.

Authors:  Yvette M van der Linden; Elsbeth Steenland; Hans C van Houwelingen; Wendy J Post; Bing Oei; Corrie A M Marijnen; Jan Willem H Leer
Journal:  Radiother Oncol       Date:  2006-03-20       Impact factor: 6.280

Review 10.  A review of human cell radiosensitivity in vitro.

Authors:  P J Deschavanne; B Fertil
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.